Cargando…
Muscle mass and estimates of renal function: a longitudinal cohort study
BACKGROUND: Creatinine is the most widely used test to estimate the glomerular filtration rate (GFR), but muscle mass as key determinant of creatinine next to renal function may confound such estimates. We explored effects of 24‐h height‐indexed creatinine excretion rate (CER index) on GFR estimated...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398222/ https://www.ncbi.nlm.nih.gov/pubmed/35596604 http://dx.doi.org/10.1002/jcsm.12969 |
_version_ | 1784772286776082432 |
---|---|
author | Groothof, Dion Post, Adrian Polinder‐Bos, Harmke A. Erler, Nicole S. Flores‐Guerrero, Jose L. Kootstra‐Ros, Jenny E. Pol, Robert A. de Borst, Martin H. Gansevoort, Ron T. Gans, Reinold O.B. Kremer, Daan Kieneker, Lyanne M. Bano, Arjola Muka, Taulant Franco, Oscar H. Bakker, Stephan J.L. |
author_facet | Groothof, Dion Post, Adrian Polinder‐Bos, Harmke A. Erler, Nicole S. Flores‐Guerrero, Jose L. Kootstra‐Ros, Jenny E. Pol, Robert A. de Borst, Martin H. Gansevoort, Ron T. Gans, Reinold O.B. Kremer, Daan Kieneker, Lyanne M. Bano, Arjola Muka, Taulant Franco, Oscar H. Bakker, Stephan J.L. |
author_sort | Groothof, Dion |
collection | PubMed |
description | BACKGROUND: Creatinine is the most widely used test to estimate the glomerular filtration rate (GFR), but muscle mass as key determinant of creatinine next to renal function may confound such estimates. We explored effects of 24‐h height‐indexed creatinine excretion rate (CER index) on GFR estimated with creatinine (eGFR(Cr)), muscle mass‐independent cystatin C (eGFR(Cys)), and the combination of creatinine and cystatin C (eGFR(Cr‐Cys)) and predicted probabilities of discordant classification given age, sex, and CER index. METHODS: We included 8076 adults enrolled in the PREVEND study. Discordant classification was defined as not having eGFR(Cr) <60 mL/min per 1.73 m(2) when eGFR(Cys) was <60 mL/min/1.73 m(2). Baseline effects of age and sex on CER index were quantified with linear models using generalized least squares. Baseline effects of CER index on eGFR were quantified with quantile regression and logistic regression. Effects of annual changes in CER index on trajectories of eGFR were quantified with linear mixed‐effects models. Missing observations in covariates were multiply imputed. RESULTS: Mean (SD) CER index was 8.0 (1.7) and 6.1 (1.3) mmol/24 h per meter in male and female participants, respectively (P (difference) < 0.001). In male participants, baseline CER index increased until 45 years of age followed by a gradual decrease, whereas a gradual decrease across the entire range of age was observed in female participants. For a 70‐year‐old male participant with low muscle mass (CER index of 2 mmol/24 h per meter), predicted baseline eGFR(Cr) and eGFR(Cys) disagreed by 24.7 mL/min/1.73 m(2) (and 30.1 mL/min/1.73 m(2) when creatinine was not corrected for race). Percentages (95% CI) of discordant classification in male and female participants aged 60 years and older with low muscle mass were 18.5% (14.8–22.1%) and 15.2% (11.4–18.5%), respectively. For a 70‐year‐old male participant who lost muscle during follow‐up, eGFR(Cr) and eGFR(Cys) disagreed by 1.5, 5.0, 8.5, and 12.0 mL/min/1.73 m(2) (and 6.7, 10.7, 13.5, and 15.9 mL/min/1.73 m(2) when creatinine was not corrected for race) at baseline, 5 years, 10 years, and 15 years of follow‐up, respectively. CONCLUSIONS: Low muscle mass may cause considerable overestimation of single measurements of eGFR(Cr). Muscle wasting may cause spurious overestimation of repeatedly measured eGFR(Cr). Implementing muscle mass‐independent markers for estimating renal function, like cystatin C as superior alternative to creatinine, is crucial to accurately assess renal function in settings of low muscle mass or muscle wasting. This would also eliminate the negative consequences of current race‐based approaches. |
format | Online Article Text |
id | pubmed-9398222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93982222022-08-24 Muscle mass and estimates of renal function: a longitudinal cohort study Groothof, Dion Post, Adrian Polinder‐Bos, Harmke A. Erler, Nicole S. Flores‐Guerrero, Jose L. Kootstra‐Ros, Jenny E. Pol, Robert A. de Borst, Martin H. Gansevoort, Ron T. Gans, Reinold O.B. Kremer, Daan Kieneker, Lyanne M. Bano, Arjola Muka, Taulant Franco, Oscar H. Bakker, Stephan J.L. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Creatinine is the most widely used test to estimate the glomerular filtration rate (GFR), but muscle mass as key determinant of creatinine next to renal function may confound such estimates. We explored effects of 24‐h height‐indexed creatinine excretion rate (CER index) on GFR estimated with creatinine (eGFR(Cr)), muscle mass‐independent cystatin C (eGFR(Cys)), and the combination of creatinine and cystatin C (eGFR(Cr‐Cys)) and predicted probabilities of discordant classification given age, sex, and CER index. METHODS: We included 8076 adults enrolled in the PREVEND study. Discordant classification was defined as not having eGFR(Cr) <60 mL/min per 1.73 m(2) when eGFR(Cys) was <60 mL/min/1.73 m(2). Baseline effects of age and sex on CER index were quantified with linear models using generalized least squares. Baseline effects of CER index on eGFR were quantified with quantile regression and logistic regression. Effects of annual changes in CER index on trajectories of eGFR were quantified with linear mixed‐effects models. Missing observations in covariates were multiply imputed. RESULTS: Mean (SD) CER index was 8.0 (1.7) and 6.1 (1.3) mmol/24 h per meter in male and female participants, respectively (P (difference) < 0.001). In male participants, baseline CER index increased until 45 years of age followed by a gradual decrease, whereas a gradual decrease across the entire range of age was observed in female participants. For a 70‐year‐old male participant with low muscle mass (CER index of 2 mmol/24 h per meter), predicted baseline eGFR(Cr) and eGFR(Cys) disagreed by 24.7 mL/min/1.73 m(2) (and 30.1 mL/min/1.73 m(2) when creatinine was not corrected for race). Percentages (95% CI) of discordant classification in male and female participants aged 60 years and older with low muscle mass were 18.5% (14.8–22.1%) and 15.2% (11.4–18.5%), respectively. For a 70‐year‐old male participant who lost muscle during follow‐up, eGFR(Cr) and eGFR(Cys) disagreed by 1.5, 5.0, 8.5, and 12.0 mL/min/1.73 m(2) (and 6.7, 10.7, 13.5, and 15.9 mL/min/1.73 m(2) when creatinine was not corrected for race) at baseline, 5 years, 10 years, and 15 years of follow‐up, respectively. CONCLUSIONS: Low muscle mass may cause considerable overestimation of single measurements of eGFR(Cr). Muscle wasting may cause spurious overestimation of repeatedly measured eGFR(Cr). Implementing muscle mass‐independent markers for estimating renal function, like cystatin C as superior alternative to creatinine, is crucial to accurately assess renal function in settings of low muscle mass or muscle wasting. This would also eliminate the negative consequences of current race‐based approaches. John Wiley and Sons Inc. 2022-05-21 2022-08 /pmc/articles/PMC9398222/ /pubmed/35596604 http://dx.doi.org/10.1002/jcsm.12969 Text en © 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Groothof, Dion Post, Adrian Polinder‐Bos, Harmke A. Erler, Nicole S. Flores‐Guerrero, Jose L. Kootstra‐Ros, Jenny E. Pol, Robert A. de Borst, Martin H. Gansevoort, Ron T. Gans, Reinold O.B. Kremer, Daan Kieneker, Lyanne M. Bano, Arjola Muka, Taulant Franco, Oscar H. Bakker, Stephan J.L. Muscle mass and estimates of renal function: a longitudinal cohort study |
title | Muscle mass and estimates of renal function: a longitudinal cohort study |
title_full | Muscle mass and estimates of renal function: a longitudinal cohort study |
title_fullStr | Muscle mass and estimates of renal function: a longitudinal cohort study |
title_full_unstemmed | Muscle mass and estimates of renal function: a longitudinal cohort study |
title_short | Muscle mass and estimates of renal function: a longitudinal cohort study |
title_sort | muscle mass and estimates of renal function: a longitudinal cohort study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398222/ https://www.ncbi.nlm.nih.gov/pubmed/35596604 http://dx.doi.org/10.1002/jcsm.12969 |
work_keys_str_mv | AT groothofdion musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT postadrian musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT polinderbosharmkea musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT erlernicoles musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT floresguerrerojosel musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT kootstrarosjennye musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT polroberta musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT deborstmartinh musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT gansevoortront musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT gansreinoldob musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT kremerdaan musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT kienekerlyannem musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT banoarjola musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT mukataulant musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT francooscarh musclemassandestimatesofrenalfunctionalongitudinalcohortstudy AT bakkerstephanjl musclemassandestimatesofrenalfunctionalongitudinalcohortstudy |